In 90 CML patients, a marked up-regulation of MSI2 is observed in every patient during CML progression, whereas Numb is down-regulated in a majority of blast crisis patients [8]. This evidence concerns the gene NUMB and chronic myelogenous leukemia, BCR-ABL1 positive.